lycorine has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, R; Huang, J; Yan, L; Zeng, H | 1 |
| Chen, F; Liang, Z; Sharopov, FS; Sun, Y; Wang, P; Wu, P; Yang, Q | 1 |
| Li, L; Ning, M; Yang, Q; Zhang, Z | 1 |
3 other study(ies) available for lycorine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Lycorine Induces Apoptosis of A549 Cells via AMPK-Mammalian Target of Rapamycin (mTOR)-S6K Signaling Pathway.
Topics: A549 Cells; Amaryllidaceae Alkaloids; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Lung Neoplasms; MAP Kinase Signaling System; Microtubule-Associated Proteins; Phenanthridines; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT).
Topics: A549 Cells; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Mice; Mice, Nude; Phenanthridines; Treatment Outcome; Wnt Signaling Pathway | 2018 |
Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis.
Topics: 3' Untranslated Regions; Amaryllidaceae Alkaloids; Apoptosis; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Humans; Lung Neoplasms; MicroRNAs; Phenanthridines; Up-Regulation | 2019 |